UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

 

 

 

(MARK ONE) 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarter ended June 30, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                    to                    

 

Commission file number:001-40019

 

 

 

PIVOTAL INVESTMENT CORPORATION III

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   84-3415215

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

The Chrysler Building

405 Lexington Avenue, 44th Floor

New York, NY10174

(Address of principal executive offices)

 

(212)-818-8800

(Issuer’s telephone number)

 

 

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act: 

 

Title of Each Class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one share of Class A Common Stock, $0.0001 par value, and one-fifth of one redeemable warrant   PICCU   OTC
Class A Common Stock, $0.0001 par value   PICC   OTC
Redeemable warrants, exercisable for shares of Class A Common Stock at an exercise price of $11.50 per share   PICCW   OTC

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ☒  Yes    No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

 

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2of the Exchange Act.

 

Large accelerated filer Accelerated filer
       
Non-accelerated filer Smaller reporting company
       
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2of the Exchange Act).    Yes      No  ☐

 

As of August 9, 2023, there were 8,562,043 shares of Class A common stock, $0.0001 par value, and 360,000 shares of Class B common stock, $0.0001 par value, issued and outstanding.

 

 

 

 

 

 

PIVOTAL INVESTMENT CORPORATION III

 

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2023

TABLE OF CONTENTS

 

    Page
Part I. Financial Information   1
Item 1. Financial Statements (Unaudited)   1
Condensed Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022   1
Condensed Statements of Operations for the three and six months ended June 30, 2023 and 2022 (Unaudited)   2
Condensed Statements of Changes in Stockholders’ Deficit for the three and six months ended June 30, 2023 and 2022 (Unaudited)   3
Condensed Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (Unaudited)   4
Notes to Unaudited Condensed Financial Statements   5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   17
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk   21
Item 4. Controls and Procedures   21
Part II. Other Information   22
Item 1A. Risk Factors   22
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   22
Item 6. Exhibits   24
Signatures   25

 

i

 

 

PART I—FINANCIAL INFORMATION

 

Item 1. Interim Financial Statements.

 

PIVOTAL INVESTMENT CORPORATION III

CONDENSED BALANCE SHEETS

 

   June 30,   December 31, 
   2023   2022 
   (Unaudited)     
ASSETS        
Current assets        
Cash  $29,096   $355,251 
Prepaid expenses   42,500    12,044 
Total Current Assets   71,596    367,295 
           
Marketable securities held in Trust Account   20,860,204    278,664,377 
TOTAL ASSETS  $20,931,800   $279,031,672 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities          
Accounts payable and accrued expenses  $2,178,730   $2,145,385 
Income taxes payable   72,385    1,778 
Redemption payable   
    258,248,749 
Total Current Liabilities   2,251,115    260,395,912 
           
Warrant liabilities   127,900    639,500 
Deferred underwriting fee payable   9,660,000    9,660,000 
TOTAL LIABILITIES   12,039,015    270,695,412 
           
Commitments and Contingencies (Note 7)   
 
    
 
 
Class A common stock subject to possible redemption 2,022,043 shares outstanding at redemption value of $10.20 and $10.07 as of June 30, 2023 and December 31, 2022, respectively   20,634,405    20,363,831 
           
Stockholders’ Deficit          
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding   
    
 
Class A common stock, $0.0001 par value, 125,000,000 shares authorized; 6,540,000 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively   654    654 
Class B common stock, $0.0001 par value; 25,000,000 shares authorized; 360,000 shares issued and outstanding, as of June 30, 2023 and December 31, 2022, respectively   36    36 
Additional paid-in capital   
    
 
Accumulated deficit   (11,742,310)   (12,028,261)
Total Stockholders’ Deficit   (11,741,620)   (12,027,571)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $20,931,800   $279,031,672 

 

The accompanying notes are an integral part of the unaudited condensed financial statements.

 

1

 

 

PIVOTAL INVESTMENT CORPORATION III

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

   For the Three Months Ended
June 30,
   For the Six Months Ended
June 30,
 
   2023   2022   2023   2022 
                 
Formation and operating costs  $131,938   $182,916   $327,289   $1,039,459 
Loss from operations   (131,938)   (182,916)   (327,289)   (1,039,459)
                     
Other income:                    
Change in fair value of warrant liabilities   511,600    4,476,500    511,600    10,743,600 
Interest earned on marketable securities held in Trust Account   245,784    318,092    444,575    353,925 
Unrealized gain on marketable securities held in Trust Account   
    8,968    
    10,831 
Total other income   757,384    4,803,560    956,175    11,108,356 
                     
Income before provision for income taxes   625,446    4,620,644    628,886    10,068,897 
Provision for income taxes   (38,007)   (5,564)   (72,361)   (5,564)
Net income  $587,439   $4,615,080   $556,525   $10,063,333 
                     
Weighted average shares outstanding, Class A common stock subject to redemption   2,022,043    27,600,000    2,022,043    27,600,000 
Basic and diluted net income per share, Class A common stock subject to redemption
  $0.07   $0.13   $0.06   $0.29 
                     
Weighted average shares outstanding, Class A common stock not subject to redemption   6,540,000    
    6,540,000    
 
Basic and diluted net income per share, Class A common stock not subject to redemption
  $0.07   $
   $0.06   $
 
                     
Weighted average shares outstanding, Class B common stock   360,000    6,900,000    360,000    6,900,000 
Basic and diluted net income per share, Class B common stock
  $0.07   $0.13   $0.06   $0.29 

 

The accompanying notes are an integral part of the unaudited condensed financial statements.

 

2

 

 

PIVOTAL INVESTMENT CORPORATION III

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(UNAUDITED)

 

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023

 

   Class A
Common Stock
   Class B
Common Stock
   Additional
Paid-in
   Accumulated   Total
Stockholders’
 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance – January 1, 2023   6,540,000   $654    360,000   $36   $
   $(12,028,261)  $(12,027,571)
Remeasurement adjustment on redeemable common stock        
 
         
 
    
 
    (129,238)   (129,238)
Net loss       
        
    
    (30,914)   (30,914)
Balance – March 31, 2023   6,540,000    654    360,000    36    
    (12,188,413)   (12,187,723)
Remeasurement adjustment on redeemable common stock                            (141,336)   (141,336)
Net income       
        
    
    587,439    587,439 
Balance – June 30, 2023   6,540,000   $654    360,000   $36   $
   $(11,742,310)  $(11,741,620)

 

 FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022

 

   Class A
Common Stock
   Class B
Common Stock
   Additional
Paid-in
   Accumulated   Total
Stockholders’
 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance – January 1, 2022   
       —
   $
         —
    6,900,000   $690   $
         —
   $(22,492,424)  $(22,491,734)
Net income       
        
    
    5,448,253    5,448,253 
Balance – March 31, 2022   
    
    6,900,000    690    
    (17,044,171)   (17,043,481)
Remeasurement adjustment on redeemable common stock                            (84,386)   (84,386)
Net income       
        
    
    4,615,080    4,615,080 
Balance – June 30, 2022   
   $
    6,900,000   $690   $
   $(12,513,477)  $(12,512,787)

 

The accompanying notes are an integral part of the unaudited condensed financial statements.

 

3

 

 

PIVOTAL INVESTMENT CORPORATION III

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   For the Six Months Ended
June 30,
 
   2023   2022 
Cash Flows from Operating Activities:        
Net income  $556,525   $10,063,333 
Adjustments to reconcile net income to net cash used in operating activities:          
Change in fair value of warrant liabilities   (511,600)   (10,743,600)
Interest earned on marketable securities held in Trust Account   (444,575)   (353,925)
Unrealized gain on marketable securities held in Trust Account   
    (10,831)
Changes in operating assets and liabilities:          
Prepaid expenses   (30,456)   56,428 
Accounts payable and accrued expenses   33,344    644,410 
Income taxes payable   70,607    5,564 
Net cash used in operating activities   (326,155)   (338,621)
Cash Flows from Investing Activities:          
Cash withdrawn from Trust Account in connection with redemption   258,248,749    
 
Net cash provided by Investing Activities:   258,248,749    
 
           
Cash Flows from Financing Activities:          
Redemption of common stock   (258,248,749)   
 
Net cash used in Financing Activities:   (258,248,749)   
 
           
Net Change in Cash   (326,155)   (338,621)
Cash – Beginning   355,251    563,923 
Cash – Ending  $29,096   $225,302 
Non-cash investing and financing activities:          
Remeasurement adjustment on redeemable common stock  $270,574   $84,386 

 

The accompanying notes are an integral part of the unaudited condensed financial statements.

 

4

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

NOTE 1. DESCRIPTION OF ORGANIZATION, GOING CONCERN AND BUSINESS OPERATIONS

 

Pivotal Investment Corporation III (the “Company”) was incorporated in Delaware on October 6, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”).

 

The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of June 30, 2023, the Company had not commenced any operations. All activity for the period from October 6, 2020 (inception) through June 30, 2023 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below and subsequent to the Initial Public Offering, and seeking to identify a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income on cash and cash equivalents in the form of interest income from the proceeds derived from the Initial Public Offering and simultaneous private placement described below.

 

The registration statement for the Company’s Initial Public Offering was declared effective on February 8, 2021. On February 11, 2021, the Company consummated the Initial Public Offering of 27,600,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of the over-allotment option in the amount of 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000, which is described in Note 3.

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,270,000 warrants (each, a “Private Placement Warrant” and, collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Pivotal Investment Holdings III LLC, a Delaware limited liability company and entity affiliated with certain of the Company’s officers (the “Sponsor”), generating gross proceeds of $7,270,000, which is described in Note 4.

 

Transaction costs amounted to $15,695,537, consisting of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees and $515,537 of other offering costs.

 

Following the closing of the Initial Public Offering on February 11, 2021, an amount of $276,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and held as cash items or invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below, except that interest earned on the Trust Account can be released to the Company to pay its tax obligations.

 

While the Company’s management has broad discretion with respect to the specific application of the cash held outside of the Trust Account, substantially all of the net proceeds from the Initial Public Offering and the sale of the Private Placement Warrants, which are placed in the Trust Account, were intended to be applied generally toward completing a Business Combination.

 

The Company was required to provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company was to seek stockholder approval of a Business Combination or conduct a tender offer was to be made by the Company, solely in its discretion. The public stockholders were entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company). There was to be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. 

 

5

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

The Company was to proceed with a Business Combination only if the Company had net tangible assets of at least $5,000,001 either immediately prior to or upon the consummation of a Business Combination and, if the Company sought stockholder approval, a majority of the shares voted were voted in favor of the Business Combination. If a stockholder vote was not required by law and the Company did not decide to hold a stockholder vote for business or other legal reasons, the Company was, pursuant to its Amended and Restated Certificate of Incorporation (the “Charter”), to conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction was required by law, or the Company decided to obtain stockholder approval for business or legal reasons, the Company was to offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company sought stockholder approval in connection with a Business Combination, the holders of Founder Shares (as defined below in Note 5) had agreed to vote their Founder Shares (as defined below in Note 5) in favor of approving a Business Combination. Additionally, each public stockholder was entitled to elect to redeem their Public Shares, without voting, and if they vote, irrespective of whether they vote for or against the proposed Business Combination.

 

Notwithstanding the above, if the Company sought stockholder approval of a Business Combination and did not conduct redemptions pursuant to the tender offer rules, the Charter provided that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), was restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.

 

The holders of Founder Shares (as defined below in Note 5) agreed (a) to waive their conversion rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Charter (i) that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, unless the Company provided the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

 

On December 30, 2022, a proposal to amend the Company’s Charter to extend the date by which the Company has to consummate a Business Combination from February 11, 2023 to August 11, 2023 was voted upon. In connection with the Meeting, the Sponsor entered into Non-Redemption Agreements with several unaffiliated third parties and agreed to transfer an aggregate of 409,051 shares of common stock to such parties in exchange for them agreeing not to redeem their public shares at the Meeting. As a result of the foregoing, effective December 30, 2022, public holders of an aggregate of 25,577,957 public shares exercised their right to redeem their public shares (leaving an aggregate of 2,022,043 public shares outstanding after the Meeting) resulting in payment to such holders of an aggregate of $258,248,749 in cash and payable as of December 31, 2022. The redemptions were paid on January 6, 2023. As of June 30, 2023 and December 31, 2022, the Company has $0 and $258,248,749 outstanding balance under redemption payable. The Company performed a valuation of the shares of common stock the Sponsor agreed to transfer to the non-redeeming third parties and determined the shares had a value of $163,620, or $0.40 per share.

 

If the Company is unable to complete a Business Combination by August 11, 2023, the Charter provides that theCompany will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

 

The holders of Founder Shares have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have waived their rights to the deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

 

6

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per share or (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company seeks to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. 

 

Risks and Uncertainties

 

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheets. The balance sheets do not include any adjustments that might result from the outcome of this uncertainty.

 

The Company is exposed to volatility in the banking market. At various times, we could have deposits with certain U.S. banks in excess of the maximum amounts insured by the U.S. Federal Deposit Insurance Corporation (“FDIC”). On March 10, 2023, Silicon Valley Bank became insolvent. State regulators closed the bank and the Federal Deposit Insurance Corporation (“FDIC”) was appointed as its receiver. The Company did not hold any deposits with Silicon Valley Bank as of June 30, 2023 and December 31, 2022.

 

Inflation Reduction Act of 2022

 

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The Treasury issued interim guidance that redemptions in connection with a SPAC liquidation would not be subject to the excise tax under certain circumstances. In addition, redemptions that occur in the same taxable year as a liquidation is completed will also be exempt from such tax.

 

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. Notwithstanding the foregoing, the Company has agreed that the per share price payable to stockholders exercising their redemption rights, whether in connection with the vote on an extension or an initial Business Combination, will not be reduced by payments required to be made by the Company under the IR Act.

 

Going Concern

 

At June 30, 2023, the Company had $29,096 in its operating bank accounts, $20,860,204 in securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital deficit of $1,953,720. As of June 30, 2023, approximately $640,000 of the amount on deposit in the Trust Account represented interest income, which is available to pay the Company’s tax obligations.

 

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

 

7

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until August 11, 2023 under the Charter to consummate a Business Combination. If a Business Combination is not consummated by this date, there is to be a mandatory liquidation and subsequent dissolution of the Company under the Charter. Management has determined that the liquidity condition, working capital deficit and potential for a mandatory liquidation raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after August 11, 2023.

 

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2022, as filed with the SEC on March 30, 2023. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

8

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.

 

Marketable Securities Held in Trust Account

 

At June 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

 

Offering Costs

 

Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the condensed statements of operations. Offering costs associated with the Class A common stock issued were charged to temporary equity upon the completion of the Initial Public Offering. Offering costs amounting to $15,168,938 were charged to stockholders’ deficit upon the completion of the Initial Public Offering and $526,599 were expensed as of the date of the Initial Public Offering.

 

Class A Common Stock Subject to Possible Redemption

 

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement adjustment from carrying value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.

 

9

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

Components of Equity

 

Upon the Initial Public Offering, the Company issued Class A common stock and Public Warrants. The Company also issued Private Placement Warrants. The Company allocated the proceeds received from the issuance using the with-and-without method. Under that method, the Company first allocated the proceeds to the Warrants based on their initial fair value measurement of $20,604,690 and then allocated the remaining proceeds, net of underwriting discounts and offering costs of $22,438,938 to the Class A common stock. On December 30, 2022, public holders of an aggregate of 25,577,957 public shares exercised their right to redeem their public shares. Following the shareholder redemption vote, the value of the 25,577,957 shares is reflected as a redemption payable. The remaining 2,022,043 of shares not redeemed are reflected in temporary equity, as these shares are subject to redemption upon the occurrence of events not solely within the Company’s control.

 

Warrant Liabilities

 

The Company assessed its warrants under ASC 480-25, “Distinguishing liabilities from equity” and ASC 815-40 “Derivatives and Hedging—Contracts in Entity’s Own Equity”. The Company accounts for the Public Warrants (as defined below) and Private Placement Warrants (collectively, the “Warrants”) as warrant liabilities. A provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Company accounts for Warrants for shares of the Company’s common stock that are not indexed to its own stock as derivative liabilities at fair value on the balance sheets and measured at fair value at inception (on the date of the Initial Public Offering) and at each reporting date in accordance with ASC 820, with changes in fair value recognized in the statements of operations in the period of change.

 

Income Taxes

 

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of June 30, 2023 and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it.

 

Our effective tax rates from continuing operations were 6.09% and 0.12% for the three months ended June 30, 2023 and 2022, respectively, and 11.51% and 0.06% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and six months ended June 30, 2023 and 2022, due to changes in fair value of warrant liabilities, and the valuation allowance on the deferred tax assets.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

 

Net Income Per Common Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per common stock is computed by dividing net income by the weighted average number of common stocks outstanding for the period. The Company applies the two-class method in calculating earnings per share. Remeasurement adjustment associated with the redeemable shares of Class A common stocks is excluded from earnings per share as the redemption value approximates fair value.

 

The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 12,790,000 shares in the calculation of diluted net income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

 

10

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):

 

   For the Three Months Ended June 30, 2023   For the Six Months Ended June 30, 2023 
   Class A   Class A   Class B   Class A   Class A   Class B 
   Redeemable   Non-Redeemable   Redeemable   Redeemable   Non-Redeemable   Redeemable 
Basic and diluted net income per common stocks                        
Numerator:                        
Allocation of net income, as adjusted  $133,134   $430,602   $23,703   $126,128   $407,942   $22,456 
Denominator:                              
Basic and diluted weighted average common stocks outstanding
   2,022,043    6,540,000    360,000    2,022,043    6,540,000    360,000 
Basic and diluted net income per common stocks
  $0.07   $0.07   $0.07   $0.06   $0.06   $0.06 

 

   For the Three Months Ended
June 30, 2022
   For the Six Months Ended
June 30, 2022
 
   Class A   Class B   Class A   Class B 
Basic and diluted net income per common stocks                
Numerator:                
Allocation of net income, as adjusted  $3,692,064   $923,016   $8,050,666   $2,012,667 
Denominator:                    
Basic and diluted weighted average common stocks outstanding
   27,600,000    6,900,000    27,600,000    6,900,000 
Basic and diluted net income per common stocks
  $0.13   $0.13   $0.29   $0.29 

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company had not experienced losses on this account.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the Company’s condensed balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 8).

 

Recently Issued Accounting Standards

 

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its financial statements.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

 

11

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

NOTE 3. INITIAL PUBLIC OFFERING

 

Pursuant to the Initial Public Offering, the Company sold 27,600,000 Units, which includes a full exercise by the underwriters of their over-allotment option in the amount of 3,600,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-fifth of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).

 

NOTE 4. PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,270,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $7,270,000 in a private placement. Each Private Placement Warrant will be exercisable to purchase one share of Class A common stock at an exercise price of $11.50. The proceeds from the sale of Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless. As a result of the difference between the purchase price of the Private Placement Warrants of $1.00 and the fair value of $1.61, the Company recorded a change of $290,800 and $4,968,000 which is recorded in the change in fair value of warrant liability for the period ended June 30, 2023 and December 31, 2022, respectively.

 

NOTE 5. RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On October 6, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 5,750,000 shares of the Company’s Class B common stock (the “Founder Shares”). Our Sponsor subsequently transferred certain shares to our officers and directors and other third parties in each case at the same per-share purchase price paid by our initial stockholders. On February 8, 2021, the Company effected a stock dividend of 0.2 shares of Class B common stock for each outstanding share of Class B common stock resulting in there being an aggregate of 6,900,000 Founder Shares outstanding. The Founder Shares will automatically convert into Class A common stock upon the consummation of a Business Combination on a one-for-one basis, subject to adjustments as described in Note 6. The Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture by the holders to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the initial stockholders will own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option, no Founder Shares are currently subject to forfeiture.

 

The holders of Founder Shares have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.

 

Related Party Advances

 

On December 30, 2021, the Company reimbursed MGG Investment Group LP, an affiliate of the Sponsor, $160,491 for payment of expenses in 2021 on behalf of the Company.

 

12

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

Related Party Loans

 

In order to finance transaction costs in connection with a Business Combination, the Company’s officer, directors, Sponsor or an affiliate of the foregoing, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination is not completed, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants.

 

Non-Redemption Agreements

 

In December 2022, the Company entered into Non-Redemption Agreements with various stockholders pursuant to which these stockholders have committed not to redeem their Public Shares. In consideration of these agreements, the Sponsor has agreed to transfer a portion of its Founder shares to the Non-Redeeming Stockholders at the closing of the Business Combination. The Company estimated the aggregate fair value of the 409,051 Founders Shares attributable to the Non-Redeeming Stockholders to be $163,620 or $0.40 per share. Each Non-Redeeming Stockholder acquired from the Sponsor an indirect economic interest in the Founder Shares. The excess of the fair value of the Founder Shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. The Company accounted for the transfer of a portion of the Sponsor’s Founders Shares to non-redeeming stockholders as a capital contribution by the Sponsor with a corresponding charge to additional paid-in capital to recognize the fair value of the shares transferred.

 

The fair value of the Founders Shares was based on the following significant inputs:

 

   December 30,
2022
 
Risk-free interest rate   4.49%
Remaining life of SPAC   1.75 
Underlying stock price  $10.12 
Probability of transaction   4.60%

 

13

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

NOTE 6. COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

Pursuant to a registration rights agreement entered into on February 8, 2021, the holders of the Founder Shares (and any shares of Class A common stock issued or issuable upon conversion of the Founder Shares), Private Placement Warrants (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants), and warrants (and any shares of Class A common stock issuable upon exercise of such warrants) that may be issued upon conversion of working capital loans have registration rights to require the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of the majority of these securities are entitled to make up to two demands that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriter’s Agreement

 

The underwriters from the Initial Public Offering are entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee will be forfeited by the underwriters solely in the event that the Company fails to complete a Business Combination, subject to the terms of the underwriting agreement.

 

NOTE 7. STOCKHOLDERS’ DEFICIT

 

Preferred Stock— The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.

 

Class A Common Stock— The Company is authorized to issue up to 125,000,000 shares of Class A, $0.0001 par value common stock. Holders of the Company’s shares of Class A common stock are entitled to one vote for each share.

 

At June 30, 2023 and December 31, 2022, there were 8,562,043 shares of Class A common stock issued and outstanding, 2,022,043 of which are presented as temporary equity. On December 30, 2022, public holders of an aggregate of 25,577,957 public shares exercised their right to redeem their public shares. The remaining 2,022,043 shares not redeemed are reflected in temporary equity, as these shares are subject to redemption upon the occurrence of events not solely within the Company’s control.

 

Class B Common Stock— The Company is authorized to issue up to 25,000,000 shares of Class B, $0.0001 par value common stock. Holders of the Company’s common stock are entitled to one vote for each share. On December 30, 2022, the Sponsor voluntarily converted 6,540,000 shares of Class B common stock of the Company it held as of such date into 6,540,000 shares of Class A common stock of the Company in accordance with the Charter. As a result, the Company has an aggregate of 360,000 shares of Class B common stock outstanding as of June 30, 2023 and December 31, 2022, respectively.

 

The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering, net of conversions, plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination, any private placement-equivalent securities issued, or to be issued, to any seller in a Business Combination, any private placement equivalent securities issued to the initial stockholders or their affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

 

14

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

On February 28, 2023, the Company received a written notice (the “Notice”) from the staff of NYSE Regulation (the “Staff”) of the New York Stock Exchange (“NYSE”) indicating that the Staff has determined to commence proceedings to delist the Company’s Class A Common Stock and units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable warrant (the “Units”), each warrant exercisable for one share of Class A Common Stock of the Company (the “Warrants”), from the NYSE pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000.

 

On July 21, 2023, the NYSE Office of General Counsel notified the Company that the Committee had determined to affirm the Staff’s decision to delist the Company’s Class A Common Stock and Units from the NYSE. Accordingly, the Class A Common Stock and units may be quoted and traded in the over-the-counter (“OTC”) market under the ticker symbols “PICC” and “PICCU,” respectively.

 

NOTE 8. FAIR VALUE MEASUREMENTS

 

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

  Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
  Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

 

At June 30, 2023 and December 31, 2022, assets held in the Trust Account were $20,860,204 and $278,664,377, respectively, which is invested primarily in U.S. Treasury Securities. Through June 30, 2023 and December 31, 2022, the Company withdrew an amount of $0 and $1,112,748 from the interest earned on the Trust Account to pay franchise and income taxes, respectively.

 

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

   Level   December 31,
2022
   June 30,
2023
 
Assets:            
Marketable securities held in Trust Account  1   $278,664,377   $20,860,204 
Liabilities:              
Warrant Liability – Private Placement Warrants  2    363,500    72,700 
Warrant Liability – Public Warrants  1    276,000    55,200 

 

15

 

 

PIVOTAL INVESTMENT CORPORATION III

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2023

(Unaudited)

 

Warrant Liabilities

 

The Warrants were accounted for as liabilities in accordance with ASC815-40and are presented within warrant liabilities on our accompanying June 30, 2023 and December 31, 2022 balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed statements of operations.

 

The Public Warrants and the Private Warrants were initially valued using a Modified Black Scholes Option Pricing Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the common stock. The expected volatility as of the IPO date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing. A Monte Carlo simulation methodology was used in estimating the fair value of the public warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Warrants. For periods subsequent to the detachment of the warrants from the Units on February 11, 2021, the close price of the public warrant price will be used as the fair value as of each relevant date. At December 31, 2021 the Private Warrants transferred to Level 2 due to the use of an observable market quote for a similar asset in an active market.

 

At June 30, 2023, the values of the Public Warrants and Private Placement Warrants were $55,200 and $72,700, respectively, based on a fair value of $0.01 per warrant.

 

At December 31, 2022, the values of the Public Warrants and Private Placement Warrants were $276,000 and $363,500, respectively, based on a fair value of $0.05 per warrant.

 

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There are no transfers between the levels for the period ended June 30, 2023 or the year ended December 31, 2022.

 

The following table presents the changes in the fair value of warrant liabilities:

 

   Private
Placement
   Public   Warrant
Liabilities
 
Fair value as of December 31, 2022  $363,500   $276,000   $639,500 
Change in valuation inputs or other assumptions   
    
    
 
Fair value as of March 31, 2023  $363,500   $276,000   $639,500 
Change in valuation inputs or other assumptions   (290,800)   (220,800)   (511,600)
Fair value as of June 30, 2023  $72,700   $55,200   $127,900 

 

NOTE 9. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events, other than listed below, that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

On July 21, 2023, the NYSE Office of General Counsel notified the Company that the Committee had determined to affirm the Staff’s decision to delist the Company’s Class A Common Stock and Units from the NYSE. Accordingly, the Class A Common Stock and units may be quoted and traded in the over-the-counter (“OTC”) market under the ticker symbols “PICC” and “PICCU,” respectively.

 

August 11, 2023, a meeting was held to approve an additional extension. Based on the number of public shares that stockholders were seeking to redeem for cash and other factors that it deemed relevant, the Company’s management determined that the Extension was no longer in the best interests of the Company and its stockholders. Accordingly, on August 11, 2023, the Company reconvened the Meeting and then closed the Meeting without considering any business. As a result, the Company expects to redeem 100% of its outstanding public shares in accordance with the terms of its current amended and restated certificate of incorporation.

 

16

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Pivotal Investment Corporation III. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Pivotal Investment Holdings III LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

We are a blank check company formed under the laws of the State of Delaware on October 6, 2020, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities (a “Business Combination”).

 

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

 

Results of Operations

 

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities from inception through June 30, 2023 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and searching for a target business with which to consummate an initial Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We expect to generate non-operating income in the form of interest income on marketable securities held after the Initial Public Offering. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

 

For the three months ended June 30, 2023, we incurred net income of $587,439, which primarily consisted of interest earned on marketable securities held in Trust Account of $245,784 and change in fair value of warrants of $511,600, offset by formation and operating costs of $131,938 and provision for income taxes of $38,007.

 

For the three months ended June 30, 2022, we incurred net income of $4,615,080, which primarily consisted of change in fair value of warrant liabilities of $4,476,500 and interest earned on marketable securities held in Trust Account of $318,092, unrealized gain on marketable securities held in Trust Account of $8,968, offset by operating and formation costs of $182,916 and provision for income taxes of $5,564.

 

17

 

 

For the six months ended June 30, 2023, we incurred net income of $556,525, which primarily consisted of interest earned on marketable securities held in Trust Account of $444,575 and change in fair value of warrants of $511,600, offset by formation and operating costs of $327,289 and provision for income taxes of $72,361.

 

For the six months ended June 30, 2022, we incurred net income of $10,063,333, which primarily consisted of change in fair value of warrant liabilities of $10,743,600 and interest earned on marketable securities held in Trust Account of $353,925, unrealized gain on marketable securities held in Trust Account of $10,831, offset by operating and formation costs of $1,039,459 and provision for income taxes of $5,564.

 

Liquidity and Capital Resources

 

On February 11, 2021, we consummated the Initial Public Offering of 27,600,000 Units, at a price of $10.00 per Unit, which includes the full exercise by the underwriter of its over-allotment option in the amount of 3,600,000 Units, generating gross proceeds of $276,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 7,270,000 Private Placement Warrants to the Sponsor at a price of $1.00 per Private Placement Warrant generating gross proceeds of $7,270,000.

 

Following the Initial Public Offering, and the sale of the Private Placement Warrants, a total of $276,000,000 was placed in the Trust Account. We incurred $15,695,537 in transaction costs, including $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees and $515,537 of other offering costs.

 

For the six months ended June 30, 2023, net cash used in operating activities was $326,155. Net income of $556,525 was affected by interest earned on marketable securities held in Trust Account of $444,575 and changes in fair value of warrants of $511,600. Changes in operating assets and liabilities provided $73,495 of cash for operating activities.

 

For the six months ended June 30, 2022, cash used in operating activities was $338,621. Net income of $10,063,333 was affected by change in fair value of warrant liabilities of $10,743,600 and interest earned on marketable securities held in Trust Account of $353,925, and unrealized gain on marketable securities held in Trust Account of $10,831. Changes in operating assets and liabilities provided $706,402 of cash for operating activities.

 

At June 30, 2023, we had marketable securities held in the Trust Account of $20,860,204 (including $639,774 of interest income and unrealized gain on marketable securities held in trust account) consisting of money market funds which are invested primarily in U.S. Treasury securities. Interest income on the balance in the Trust Account may be used by us to pay taxes.

 

We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

 

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required.

 

If we are unable to raise such additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance date of the condensed financial statements.

 

18

 

 

Going Concern

 

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until August 11, 2023 to consummate a Business Combination unless stockholders otherwise approve an additional extension of time to consummate a Business Combination. If a Business Combination is not consummated by this date the Company’s charter provides for a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the low cash balance as well as the potential mandatory liquidation raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after August 11, 2023. The Company is within 12 months of its mandatory liquidation date as of the time of filing of this Quarterly Report on Form 10-Q.

 

Off-Balance Sheet Financing Arrangements

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2023. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Contractual Obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than described below.

 

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee will be forfeited by the underwriters solely in the event that the Company fails to complete a Business Combination, subject to the terms of the underwriting agreement. 

 

Critical Accounting Policies

 

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

 

Warrant Liabilities

 

The company assessed its warrants under ASC 480-25, “Distinguishing liabilities from equity” and ASC 815-40 “Derivatives and Hedging—Contracts in Entity’s Own Equity”. The Company accounts for the Public Warrants (as defined below) and Private Placement Warrants (collectively, the “Warrants”) as derivative liabilities. A provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Company accounts for Warrants for shares of the Company’s common stock that are not indexed to its own stock as derivative liabilities at fair value on the condensed balance sheets and measured at fair value at inception (on the date of the Initial Public Offering) and at each reporting date in accordance with ASC 820, with changes in fair value recognized in the condensed statements of operations in the period of change.

 

19

 

 

Common Stock Subject to Possible Redemption

 

We account for our common stock subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A Common stock subject to mandatory redemption is classified as a liability instrument and measured at fair value. Conditionally redeemable shares of Class A common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of our condensed balance sheets.

 

We recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount value. The change in the carrying value of redeemable common stock resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.

 

Net Income Per Common Share

 

We comply with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” We have two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of stock. Net income per common share is calculated by dividing the net income by the weighted average number of common stock outstanding for the respective period. We did not consider the effect of the warrants issued in connection with the initial public offering and the private placement in the calculation of diluted net income per common share because their exercise is contingent upon future events. As a result, diluted net income per common share is the same as basic net income per common share. Remeasurement associated with the redeemable Class A common stock is excluded from net income per common share as the redemption value approximates fair value.

 

Recent Accounting Standards

 

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its financial statements.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

 

20

 

 

Use of Estimates

 

The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2023. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective, due to the material weakness in our internal control over financial reporting related to the Company’s accounting for complex financial instruments and related party transactions. As a result, we performed additional analysis as deemed necessary to ensure that our condensed financial statements were prepared in accordance with GAAP. Accordingly, management believes that the condensed financial statements included in this Quarter Report present fairly in all material respects our condensed financial position, results of operations and cash flows for the period presented.

 

Management has identified a material weakness in internal controls related to the accounting for complex financial instruments and review of related party transactions. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to continue to enhance our system of evaluating and implementing the accounting standards that apply to our condensed financial statements, including enhanced analyses by our personnel and third-party professionals with whom we consult regarding complex accounting applications, including the identification and disclosure of related party transactions. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

21

 

 

PART II - OTHER INFORMATION

 

Item 1A. Risk Factors

 

As of the date of this Quarterly Report, there have been no material changes with respect to those risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022 except as set forth below. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

 

We identified an additional material weakness in our internal control over financial reporting relating to our complex financial instruments and related party transactions. This material weakness could continue to adversely affect our ability to report our results of operations and financial condition accurately and in a timely manner.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the condensed financial statements for external purposes in accordance with GAAP. Our management also evaluates the effectiveness of our internal controls and we will disclose any changes and material weaknesses identified through such evaluation in those internal controls. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim condensed financial statements will not be prevented or detected on a timely basis.

 

As described elsewhere in this report, in connection with the preparation of our condensed financial statements as of June 30, 2023, management identified errors made in our historical condensed financial statements where we improperly classified some of our Class A common stock subject to possible redemption. We previously determined the Class A common stock subject to possible redemption to be equal to the redemption value of $10.00 per share of Class A common stock while also taking into consideration that a redemption cannot result in net tangible assets being less than $5,000,001 pursuant to the Charter. Management determined that the Class A common stock issued during our initial public offering can be redeemed or become redeemable subject to the occurrence of future events considered outside our control. Therefore, management concluded that temporary equity should include all shares of Class A common stock subject to possible redemption. As a result, management has noted a classification error related to temporary equity and permanent equity. This resulted in a restatement to the initial carrying value of the Class A common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A common stock. Management concluded that the foregoing constituted a material weakness as of June 30, 2023. Management also identified errors in our identification and disclosure of related party transactions.

 

As a result, we performed additional analysis as deemed necessary to ensure that our condensed financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the condensed financial statements included in this Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented. However, we cannot assure you that the foregoing will not result in any future material weaknesses or deficiencies in internal control over financial reporting. Even though we have strengthened our controls and procedures, in the future those controls and procedures may not be adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of our condensed financial statements.

 

22

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

On February 11, 2021, we consummated the Initial Public Offering of 27,600,000 Units, which includes the full exercise by the underwriter of its over-allotment option in the amount of 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000. Citigroup acted as sole the book-running manager of the Initial Public Offering. The securities in the offering were registered under the Securities Act on registration statements on Form S-1 (No. 333-252080 and 333-252527). The Securities and Exchange Commission declared the registration statements effective on February 8, 2021.

 

Simultaneous with the consummation of the Initial Public Offering, and the full exercise of the over-allotment option, we consummated the private placement of an aggregate of 7,270,000 Private Placement Warrants to the Sponsor at a price of $1.00 per Private Placement Warrant, generating total proceeds of $7,270,000. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

 

The Private Placement Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.

 

We paid a total of $5,520,000 in underwriting discounts and commission and $515,537 for other costs and expenses related to the Initial Public Offering. In addition, the underwriters agreed to defer up to $9,660,000 in underwriting discounts and commissions.

 

Of the gross proceeds received from the Initial Public Offering including the over-allotment option, and the Private Placement Warrants, $276,000,000 was placed in the Trust Account and shall be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders. For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.

 

23

 

 

Item 6. Exhibits

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

No.   Description of Exhibit
   
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
31.2*   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
32.1**   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   
101.INS*   Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Online XBRL Document
   
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
   
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB*   Inline XBRL Taxonomy Extension Labels Linkbase Document
   
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
   
104*   The cover page from the Company’s Quarterly report on Form10-Q for the quarter ended June 30, 2023 has been formatted in Inline XBRL and is included in Exhibits 101.

 

*Filed herewith.
**Furnished.

 

24

 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  PIVOTAL INVESTMENT CORPORATION III
     
Date: August 14, 2023 By: /s/ Kevin Griffin
  Name:  Kevin Griffin
  Title:

Chief Executive Officer and President

(Principal Executive Officer)

     
Date: August 14, 2023 By: /s/ James H. R. Brady
  Name: James H.R. Brady
  Title:

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

25

 

818-8800 NONE NONE NONE 0.06 0.07 0.13 0.29 0.06 0.07 0.06 0.07 0.13 0.29 2022043 2022043 6540000 6540000 360000 360000 0.06 0.06 0.06 0.07 0.07 0.07 27600000 27600000 6900000 6900000 0.13 0.13 0.29 0.29 false --12-31 Q2 0001835800 0001835800 2023-01-01 2023-06-30 0001835800 picc:UnitsEachConsistingOfOneShareOfClassACommonStock00001ParValueAndOnefifthOfOneRedeemableWarrantMember 2023-01-01 2023-06-30 0001835800 picc:ClassACommonStock00001ParValueMember 2023-01-01 2023-06-30 0001835800 picc:RedeemableWarrantsExercisableForSharesOfClassACommonStockAtAnExercisePriceOf1150PerShareMember 2023-01-01 2023-06-30 0001835800 us-gaap:CommonClassAMember 2023-08-09 0001835800 us-gaap:CommonClassBMember 2023-08-09 0001835800 2023-06-30 0001835800 2022-12-31 0001835800 us-gaap:CommonClassAMember 2023-06-30 0001835800 us-gaap:CommonClassAMember 2022-12-31 0001835800 us-gaap:CommonClassBMember 2023-06-30 0001835800 us-gaap:CommonClassBMember 2022-12-31 0001835800 2023-04-01 2023-06-30 0001835800 2022-04-01 2022-06-30 0001835800 2022-01-01 2022-06-30 0001835800 picc:ClassACommonStockSubjectToRedemptionMember 2023-04-01 2023-06-30 0001835800 picc:ClassACommonStockSubjectToRedemptionMember 2022-04-01 2022-06-30 0001835800 picc:ClassACommonStockSubjectToRedemptionMember 2023-01-01 2023-06-30 0001835800 picc:ClassACommonStockSubjectToRedemptionMember 2022-01-01 2022-06-30 0001835800 us-gaap:CommonClassAMember 2023-04-01 2023-06-30 0001835800 us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001835800 us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0001835800 us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001835800 us-gaap:CommonClassBMember 2023-04-01 2023-06-30 0001835800 us-gaap:CommonClassBMember 2022-04-01 2022-06-30 0001835800 us-gaap:CommonClassBMember 2023-01-01 2023-06-30 0001835800 us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001835800 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001835800 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001835800 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001835800 us-gaap:RetainedEarningsMember 2022-12-31 0001835800 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001835800 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001835800 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001835800 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001835800 2023-01-01 2023-03-31 0001835800 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001835800 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001835800 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001835800 us-gaap:RetainedEarningsMember 2023-03-31 0001835800 2023-03-31 0001835800 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001835800 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001835800 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001835800 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001835800 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0001835800 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001835800 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001835800 us-gaap:RetainedEarningsMember 2023-06-30 0001835800 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001835800 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001835800 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001835800 us-gaap:RetainedEarningsMember 2021-12-31 0001835800 2021-12-31 0001835800 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001835800 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001835800 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001835800 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001835800 2022-01-01 2022-03-31 0001835800 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001835800 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001835800 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001835800 us-gaap:RetainedEarningsMember 2022-03-31 0001835800 2022-03-31 0001835800 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001835800 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001835800 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001835800 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001835800 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001835800 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001835800 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001835800 us-gaap:RetainedEarningsMember 2022-06-30 0001835800 2022-06-30 0001835800 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-02-11 2021-02-11 0001835800 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-02-11 2021-02-11 0001835800 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-02-11 0001835800 us-gaap:IPOMember 2021-02-11 2021-02-11 0001835800 us-gaap:PrivatePlacementMember 2023-06-30 0001835800 us-gaap:WarrantMember 2023-06-30 0001835800 us-gaap:PrivatePlacementMember 2023-01-01 2023-06-30 0001835800 2021-02-11 2021-02-11 0001835800 us-gaap:IPOMember 2021-02-11 0001835800 us-gaap:IPOMember 2023-01-01 2023-06-30 0001835800 us-gaap:CommonStockMember 2022-12-30 0001835800 us-gaap:CommonStockMember 2022-12-30 2022-12-30 0001835800 2022-12-30 2022-12-30 0001835800 2022-01-01 2022-12-31 0001835800 picc:SponsorMember 2023-06-30 0001835800 picc:TrustAccountMember 2023-06-30 0001835800 picc:USFederalMember 2022-08-16 2022-08-16 0001835800 2022-08-16 2022-08-16 0001835800 us-gaap:IPOMember 2023-06-30 0001835800 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-01-01 2023-06-30 0001835800 us-gaap:CommonClassAMember 2022-12-30 0001835800 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001835800 picc:ClassARedeemableMember 2023-04-01 2023-06-30 0001835800 picc:ClassANonRedeemableMember 2023-04-01 2023-06-30 0001835800 picc:ClassBRedeemableMember 2023-04-01 2023-06-30 0001835800 picc:ClassARedeemableMember 2023-01-01 2023-06-30 0001835800 picc:ClassANonRedeemableMember 2023-01-01 2023-06-30 0001835800 picc:ClassBRedeemableMember 2023-01-01 2023-06-30 0001835800 picc:ClassAMember 2022-04-01 2022-06-30 0001835800 picc:ClassAMember 2022-01-01 2022-06-30 0001835800 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2023-01-01 2023-06-30 0001835800 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2023-06-30 0001835800 picc:PublicWarrantsMember us-gaap:CommonClassAMember 2023-06-30 0001835800 picc:SponsorMember us-gaap:PrivatePlacementMember 2023-06-30 0001835800 us-gaap:CommonClassAMember picc:PublicWarrantsMember 2023-06-30 0001835800 us-gaap:PrivatePlacementMember 2022-12-31 0001835800 picc:SponsorMember 2020-10-06 2020-10-06 0001835800 picc:SponsorMember us-gaap:CommonClassBMember 2021-02-08 2021-02-08 0001835800 picc:SponsorMember us-gaap:CommonClassBMember 2021-02-08 0001835800 us-gaap:CommonClassBMember 2021-02-08 2021-02-08 0001835800 picc:SponsorMember us-gaap:CommonClassAMember 2023-06-30 0001835800 2021-01-01 2021-12-30 0001835800 picc:WorkingCapitalLoanMember 2023-01-01 2023-06-30 0001835800 picc:WorkingCapitalLoanMember 2023-06-30 0001835800 picc:NonRedemptionAgreementsMember 2022-01-01 2022-12-31 0001835800 2022-01-01 2022-12-30 0001835800 2022-12-30 0001835800 picc:SponsorMember us-gaap:CommonClassAMember 2023-06-30 0001835800 us-gaap:CommonClassAMember 2022-12-30 2022-12-30 0001835800 picc:SponsorMember us-gaap:CommonClassBMember 2022-12-30 2022-12-30 0001835800 picc:SponsorMember us-gaap:CommonClassAMember 2022-12-30 2022-12-30 0001835800 us-gaap:CommonClassBMember 2022-01-01 2022-12-31 0001835800 2023-02-28 2023-02-28 0001835800 2023-02-28 0001835800 picc:PublicWarrantsMember 2023-06-30 0001835800 picc:PublicWarrantsMember 2022-12-31 0001835800 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001835800 us-gaap:FairValueInputsLevel1Member 2023-06-30 0001835800 us-gaap:FairValueInputsLevel2Member us-gaap:PrivatePlacementMember 2022-12-31 0001835800 us-gaap:FairValueInputsLevel2Member us-gaap:PrivatePlacementMember 2023-06-30 0001835800 us-gaap:FairValueInputsLevel1Member picc:PublicWarrantsMember 2022-12-31 0001835800 us-gaap:FairValueInputsLevel1Member picc:PublicWarrantsMember 2023-06-30 0001835800 picc:WarrantLiabilitiesMember 2022-12-31 0001835800 us-gaap:PrivatePlacementMember 2023-01-01 2023-03-31 0001835800 picc:PublicWarrantsMember 2023-01-01 2023-03-31 0001835800 picc:WarrantLiabilitiesMember 2023-01-01 2023-03-31 0001835800 us-gaap:PrivatePlacementMember 2023-03-31 0001835800 picc:PublicWarrantsMember 2023-03-31 0001835800 picc:WarrantLiabilitiesMember 2023-03-31 0001835800 us-gaap:PrivatePlacementMember 2023-04-01 2023-06-30 0001835800 picc:PublicWarrantsMember 2023-04-01 2023-06-30 0001835800 picc:WarrantLiabilitiesMember 2023-04-01 2023-06-30 0001835800 picc:WarrantLiabilitiesMember 2023-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRESIDENT

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Kevin Griffin, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of PIVOTAL INVESTMENT CORPORATION III;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2023

 

  /s/ Kevin Griffin
  Kevin Griffin
  Chief Executive Officer and President
  (Principal Executive Officer)

 

 

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, James H.R. Brady, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Pivotal Investment Corporation III.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2023

 

  /s/ James H.R. Brady
  James H.R. Brady
  Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of PIVOTAL INVESTMENT CORPORATION III (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Kevin Griffin, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: August 14, 2023

 

  /s/ Kevin Griffin
  Kevin Griffin
  Chief Executive Officer and President
  (Principal Executive Officer)

 

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Pivotal Investment Corporation III (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, James H.R. Brady, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: August 14, 2023

 

  /s/ James H.R. Brady
  James H.R. Brady
  Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

 

v3.23.2
Document And Entity Information - shares
6 Months Ended
Jun. 30, 2023
Aug. 09, 2023
Document Information Line Items    
Entity Registrant Name PIVOTAL INVESTMENT CORPORATION III  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Entity Central Index Key 0001835800  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Jun. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company true  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-40019  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 84-3415215  
Entity Address, Address Line One The Chrysler Building  
Entity Address, Address Line Two 405 Lexington Avenue  
Entity Address, Address Line Three 44th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10174  
City Area Code (212)  
Local Phone Number 818-8800  
Entity Interactive Data Current Yes  
Units, each consisting of one share of Class A Common Stock, $0.0001 par value, and one-fifth of one redeemable warrant    
Document Information Line Items    
Trading Symbol PICCU  
Title of 12(b) Security Units, each consisting of one share of Class A Common Stock, $0.0001 par value, and one-fifth of one redeemable warrant  
Security Exchange Name NONE  
Class A Common Stock, $0.0001 par value    
Document Information Line Items    
Trading Symbol PICC  
Title of 12(b) Security Class A Common Stock, $0.0001 par value  
Security Exchange Name NONE  
Redeemable warrants, exercisable for shares of Class A Common Stock at an exercise price of $11.50 per share    
Document Information Line Items    
Trading Symbol PICCW  
Title of 12(b) Security Redeemable warrants, exercisable for shares of Class A Common Stock at an exercise price of $11.50 per share  
Security Exchange Name NONE  
Class A Common Stock    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   8,562,043
Class B Common Stock    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   360,000
v3.23.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets    
Cash $ 29,096 $ 355,251
Prepaid expenses 42,500 12,044
Total Current Assets 71,596 367,295
Marketable securities held in Trust Account 20,860,204 278,664,377
TOTAL ASSETS 20,931,800 279,031,672
Current liabilities    
Accounts payable and accrued expenses 2,178,730 2,145,385
Income taxes payable 72,385 1,778
Redemption payable 258,248,749
Total Current Liabilities 2,251,115 260,395,912
Warrant liabilities 127,900 639,500
Deferred underwriting fee payable 9,660,000 9,660,000
TOTAL LIABILITIES 12,039,015 270,695,412
Commitments and Contingencies (Note 7)
Class A common stock subject to possible redemption 2,022,043 shares outstanding at redemption value of $10.20 and $10.07 as of June 30, 2023 and December 31, 2022, respectively 20,634,405 20,363,831
Stockholders’ Deficit    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Additional paid-in capital
Accumulated deficit (11,742,310) (12,028,261)
Total Stockholders’ Deficit (11,741,620) (12,027,571)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 20,931,800 279,031,672
Class A Common Stock    
Stockholders’ Deficit    
Common stock value 654 654
Class B Common Stock    
Stockholders’ Deficit    
Common stock value $ 36 $ 36
v3.23.2
Condensed Balance Sheets (Parentheticals) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Class A Common Stock    
Common stock subject to possible redemption, shares outstanding 2,022,043 2,022,043
Common stock subject to possible redemption, shares price (in Dollars per share) $ 10.2 $ 10.07
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 125,000,000 125,000,000
Common stock, shares issued 6,540,000 6,540,000
Common stock, shares outstanding 6,540,000 6,540,000
Class B Common Stock    
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 25,000,000 25,000,000
Common stock, shares issued 360,000 360,000
Common stock, shares outstanding 360,000 360,000
v3.23.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Formation and operating costs $ 131,938 $ 182,916 $ 327,289 $ 1,039,459
Loss from operations (131,938) (182,916) (327,289) (1,039,459)
Other income:        
Change in fair value of warrant liabilities 511,600 4,476,500 511,600 10,743,600
Interest earned on marketable securities held in Trust Account 245,784 318,092 444,575 353,925
Unrealized gain on marketable securities held in Trust Account 8,968 10,831
Total other income 757,384 4,803,560 956,175 11,108,356
Income before provision for income taxes 625,446 4,620,644 628,886 10,068,897
Provision for income taxes (38,007) (5,564) (72,361) (5,564)
Net income $ 587,439 $ 4,615,080 $ 556,525 $ 10,063,333
Class A Common Stock Subject to Redemption        
Other income:        
Weighted average shares outstanding (in Shares) 2,022,043 27,600,000 2,022,043 27,600,000
Basic net income per share (in Dollars per share) $ 0.07 $ 0.13 $ 0.06 $ 0.29
Class A Common Stock        
Other income:        
Weighted average shares outstanding (in Shares) 6,540,000 6,540,000
Basic net income per share (in Dollars per share) $ 0.07 $ 0.06
Class B Common Stock        
Other income:        
Weighted average shares outstanding (in Shares) 360,000 6,900,000 360,000 6,900,000
Basic net income per share (in Dollars per share) $ 0.07 $ 0.13 $ 0.06 $ 0.29
v3.23.2
Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Class A Common Stock Subject to Redemption        
Diluted net income per share $ 0.07 $ 0.13 $ 0.06 $ 0.29
Class A Common Stock        
Diluted net income per share 0.07 0.06
Class B Common Stock        
Diluted net income per share $ 0.07 $ 0.13 $ 0.06 $ 0.29
v3.23.2
Condensed Statements of Changes in Stockholders’ Deficit (Unaudited) - USD ($)
Class A
Common Stock
Class B
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 690 $ (22,492,424) $ (22,491,734)
Balance (in Shares) at Dec. 31, 2021 6,900,000      
Net income (loss) 5,448,253 5,448,253
Balance at Mar. 31, 2022 $ 690 (17,044,171) (17,043,481)
Balance (in Shares) at Mar. 31, 2022 6,900,000      
Balance at Dec. 31, 2021 $ 690 (22,492,424) (22,491,734)
Balance (in Shares) at Dec. 31, 2021 6,900,000      
Net income (loss)         10,063,333
Balance at Jun. 30, 2022 $ 690 (12,513,477) (12,512,787)
Balance (in Shares) at Jun. 30, 2022 6,900,000      
Balance at Mar. 31, 2022 $ 690 (17,044,171) (17,043,481)
Balance (in Shares) at Mar. 31, 2022 6,900,000      
Remeasurement adjustment on redeemable common stock       (84,386) (84,386)
Net income (loss) 4,615,080 4,615,080
Balance at Jun. 30, 2022 $ 690 (12,513,477) (12,512,787)
Balance (in Shares) at Jun. 30, 2022 6,900,000      
Balance at Dec. 31, 2022 $ 654 $ 36 (12,028,261) (12,027,571)
Balance (in Shares) at Dec. 31, 2022 6,540,000 360,000      
Remeasurement adjustment on redeemable common stock (129,238) (129,238)
Net income (loss) (30,914) (30,914)
Balance at Mar. 31, 2023 $ 654 $ 36 (12,188,413) (12,187,723)
Balance (in Shares) at Mar. 31, 2023 6,540,000 360,000      
Balance at Dec. 31, 2022 $ 654 $ 36 (12,028,261) (12,027,571)
Balance (in Shares) at Dec. 31, 2022 6,540,000 360,000      
Net income (loss)         556,525
Balance at Jun. 30, 2023 $ 654 $ 36 (11,742,310) (11,741,620)
Balance (in Shares) at Jun. 30, 2023 6,540,000 360,000      
Balance at Mar. 31, 2023 $ 654 $ 36 (12,188,413) (12,187,723)
Balance (in Shares) at Mar. 31, 2023 6,540,000 360,000      
Remeasurement adjustment on redeemable common stock       (141,336) (141,336)
Net income (loss) 587,439 587,439
Balance at Jun. 30, 2023 $ 654 $ 36 $ (11,742,310) $ (11,741,620)
Balance (in Shares) at Jun. 30, 2023 6,540,000 360,000      
v3.23.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities:    
Net income $ 556,525 $ 10,063,333
Adjustments to reconcile net income to net cash used in operating activities:    
Change in fair value of warrant liabilities (511,600) (10,743,600)
Interest earned on marketable securities held in Trust Account (444,575) (353,925)
Unrealized gain on marketable securities held in Trust Account (10,831)
Changes in operating assets and liabilities:    
Prepaid expenses (30,456) 56,428
Accounts payable and accrued expenses 33,344 644,410
Income taxes payable 70,607 5,564
Net cash used in operating activities (326,155) (338,621)
Cash Flows from Investing Activities:    
Cash withdrawn from Trust Account in connection with redemption 258,248,749
Net cash provided by Investing Activities: 258,248,749
Cash Flows from Financing Activities:    
Redemption of common stock (258,248,749)
Net cash used in Financing Activities: (258,248,749)
Net Change in Cash (326,155) (338,621)
Cash – Beginning 355,251 563,923
Cash – Ending 29,096 225,302
Non-cash investing and financing activities:    
Remeasurement adjustment on redeemable common stock $ 270,574 $ 84,386
v3.23.2
Description of Organization, Going Concern And Business Operations
6 Months Ended
Jun. 30, 2023
Description of Organization, Going Concern And Business Operations [Abstract]  
DESCRIPTION OF ORGANIZATION, GOING CONCERN AND BUSINESS OPERATIONS

NOTE 1. DESCRIPTION OF ORGANIZATION, GOING CONCERN AND BUSINESS OPERATIONS

 

Pivotal Investment Corporation III (the “Company”) was incorporated in Delaware on October 6, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”).

 

The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of June 30, 2023, the Company had not commenced any operations. All activity for the period from October 6, 2020 (inception) through June 30, 2023 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below and subsequent to the Initial Public Offering, and seeking to identify a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income on cash and cash equivalents in the form of interest income from the proceeds derived from the Initial Public Offering and simultaneous private placement described below.

 

The registration statement for the Company’s Initial Public Offering was declared effective on February 8, 2021. On February 11, 2021, the Company consummated the Initial Public Offering of 27,600,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of the over-allotment option in the amount of 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000, which is described in Note 3.

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,270,000 warrants (each, a “Private Placement Warrant” and, collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Pivotal Investment Holdings III LLC, a Delaware limited liability company and entity affiliated with certain of the Company’s officers (the “Sponsor”), generating gross proceeds of $7,270,000, which is described in Note 4.

 

Transaction costs amounted to $15,695,537, consisting of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees and $515,537 of other offering costs.

 

Following the closing of the Initial Public Offering on February 11, 2021, an amount of $276,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and held as cash items or invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below, except that interest earned on the Trust Account can be released to the Company to pay its tax obligations.

 

While the Company’s management has broad discretion with respect to the specific application of the cash held outside of the Trust Account, substantially all of the net proceeds from the Initial Public Offering and the sale of the Private Placement Warrants, which are placed in the Trust Account, were intended to be applied generally toward completing a Business Combination.

 

The Company was required to provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company was to seek stockholder approval of a Business Combination or conduct a tender offer was to be made by the Company, solely in its discretion. The public stockholders were entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company). There was to be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. 

 

The Company was to proceed with a Business Combination only if the Company had net tangible assets of at least $5,000,001 either immediately prior to or upon the consummation of a Business Combination and, if the Company sought stockholder approval, a majority of the shares voted were voted in favor of the Business Combination. If a stockholder vote was not required by law and the Company did not decide to hold a stockholder vote for business or other legal reasons, the Company was, pursuant to its Amended and Restated Certificate of Incorporation (the “Charter”), to conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction was required by law, or the Company decided to obtain stockholder approval for business or legal reasons, the Company was to offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company sought stockholder approval in connection with a Business Combination, the holders of Founder Shares (as defined below in Note 5) had agreed to vote their Founder Shares (as defined below in Note 5) in favor of approving a Business Combination. Additionally, each public stockholder was entitled to elect to redeem their Public Shares, without voting, and if they vote, irrespective of whether they vote for or against the proposed Business Combination.

 

Notwithstanding the above, if the Company sought stockholder approval of a Business Combination and did not conduct redemptions pursuant to the tender offer rules, the Charter provided that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), was restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.

 

The holders of Founder Shares (as defined below in Note 5) agreed (a) to waive their conversion rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Charter (i) that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, unless the Company provided the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

 

On December 30, 2022, a proposal to amend the Company’s Charter to extend the date by which the Company has to consummate a Business Combination from February 11, 2023 to August 11, 2023 was voted upon. In connection with the Meeting, the Sponsor entered into Non-Redemption Agreements with several unaffiliated third parties and agreed to transfer an aggregate of 409,051 shares of common stock to such parties in exchange for them agreeing not to redeem their public shares at the Meeting. As a result of the foregoing, effective December 30, 2022, public holders of an aggregate of 25,577,957 public shares exercised their right to redeem their public shares (leaving an aggregate of 2,022,043 public shares outstanding after the Meeting) resulting in payment to such holders of an aggregate of $258,248,749 in cash and payable as of December 31, 2022. The redemptions were paid on January 6, 2023. As of June 30, 2023 and December 31, 2022, the Company has $0 and $258,248,749 outstanding balance under redemption payable. The Company performed a valuation of the shares of common stock the Sponsor agreed to transfer to the non-redeeming third parties and determined the shares had a value of $163,620, or $0.40 per share.

 

If the Company is unable to complete a Business Combination by August 11, 2023, the Charter provides that theCompany will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

 

The holders of Founder Shares have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have waived their rights to the deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per share or (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company seeks to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. 

 

Risks and Uncertainties

 

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheets. The balance sheets do not include any adjustments that might result from the outcome of this uncertainty.

 

The Company is exposed to volatility in the banking market. At various times, we could have deposits with certain U.S. banks in excess of the maximum amounts insured by the U.S. Federal Deposit Insurance Corporation (“FDIC”). On March 10, 2023, Silicon Valley Bank became insolvent. State regulators closed the bank and the Federal Deposit Insurance Corporation (“FDIC”) was appointed as its receiver. The Company did not hold any deposits with Silicon Valley Bank as of June 30, 2023 and December 31, 2022.

 

Inflation Reduction Act of 2022

 

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The Treasury issued interim guidance that redemptions in connection with a SPAC liquidation would not be subject to the excise tax under certain circumstances. In addition, redemptions that occur in the same taxable year as a liquidation is completed will also be exempt from such tax.

 

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. Notwithstanding the foregoing, the Company has agreed that the per share price payable to stockholders exercising their redemption rights, whether in connection with the vote on an extension or an initial Business Combination, will not be reduced by payments required to be made by the Company under the IR Act.

 

Going Concern

 

At June 30, 2023, the Company had $29,096 in its operating bank accounts, $20,860,204 in securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital deficit of $1,953,720. As of June 30, 2023, approximately $640,000 of the amount on deposit in the Trust Account represented interest income, which is available to pay the Company’s tax obligations.

 

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

 

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until August 11, 2023 under the Charter to consummate a Business Combination. If a Business Combination is not consummated by this date, there is to be a mandatory liquidation and subsequent dissolution of the Company under the Charter. Management has determined that the liquidity condition, working capital deficit and potential for a mandatory liquidation raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after August 11, 2023.

v3.23.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2023
Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2022, as filed with the SEC on March 30, 2023. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.

 

Marketable Securities Held in Trust Account

 

At June 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

 

Offering Costs

 

Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the condensed statements of operations. Offering costs associated with the Class A common stock issued were charged to temporary equity upon the completion of the Initial Public Offering. Offering costs amounting to $15,168,938 were charged to stockholders’ deficit upon the completion of the Initial Public Offering and $526,599 were expensed as of the date of the Initial Public Offering.

 

Class A Common Stock Subject to Possible Redemption

 

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement adjustment from carrying value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.

 

Components of Equity

 

Upon the Initial Public Offering, the Company issued Class A common stock and Public Warrants. The Company also issued Private Placement Warrants. The Company allocated the proceeds received from the issuance using the with-and-without method. Under that method, the Company first allocated the proceeds to the Warrants based on their initial fair value measurement of $20,604,690 and then allocated the remaining proceeds, net of underwriting discounts and offering costs of $22,438,938 to the Class A common stock. On December 30, 2022, public holders of an aggregate of 25,577,957 public shares exercised their right to redeem their public shares. Following the shareholder redemption vote, the value of the 25,577,957 shares is reflected as a redemption payable. The remaining 2,022,043 of shares not redeemed are reflected in temporary equity, as these shares are subject to redemption upon the occurrence of events not solely within the Company’s control.

 

Warrant Liabilities

 

The Company assessed its warrants under ASC 480-25, “Distinguishing liabilities from equity” and ASC 815-40 “Derivatives and Hedging—Contracts in Entity’s Own Equity”. The Company accounts for the Public Warrants (as defined below) and Private Placement Warrants (collectively, the “Warrants”) as warrant liabilities. A provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Company accounts for Warrants for shares of the Company’s common stock that are not indexed to its own stock as derivative liabilities at fair value on the balance sheets and measured at fair value at inception (on the date of the Initial Public Offering) and at each reporting date in accordance with ASC 820, with changes in fair value recognized in the statements of operations in the period of change.

 

Income Taxes

 

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of June 30, 2023 and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it.

 

Our effective tax rates from continuing operations were 6.09% and 0.12% for the three months ended June 30, 2023 and 2022, respectively, and 11.51% and 0.06% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and six months ended June 30, 2023 and 2022, due to changes in fair value of warrant liabilities, and the valuation allowance on the deferred tax assets.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

 

Net Income Per Common Share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per common stock is computed by dividing net income by the weighted average number of common stocks outstanding for the period. The Company applies the two-class method in calculating earnings per share. Remeasurement adjustment associated with the redeemable shares of Class A common stocks is excluded from earnings per share as the redemption value approximates fair value.

 

The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 12,790,000 shares in the calculation of diluted net income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

 

The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):

 

   For the Three Months Ended June 30, 2023   For the Six Months Ended June 30, 2023 
   Class A   Class A   Class B   Class A   Class A   Class B 
   Redeemable   Non-Redeemable   Redeemable   Redeemable   Non-Redeemable   Redeemable 
Basic and diluted net income per common stocks                        
Numerator:                        
Allocation of net income, as adjusted  $133,134   $430,602   $23,703   $126,128   $407,942   $22,456 
Denominator:                              
Basic and diluted weighted average common stocks outstanding
   2,022,043    6,540,000    360,000    2,022,043    6,540,000    360,000 
Basic and diluted net income per common stocks
  $0.07   $0.07   $0.07   $0.06   $0.06   $0.06 

 

   For the Three Months Ended
June 30, 2022
   For the Six Months Ended
June 30, 2022
 
   Class A   Class B   Class A   Class B 
Basic and diluted net income per common stocks                
Numerator:                
Allocation of net income, as adjusted  $3,692,064   $923,016   $8,050,666   $2,012,667 
Denominator:                    
Basic and diluted weighted average common stocks outstanding
   27,600,000    6,900,000    27,600,000    6,900,000 
Basic and diluted net income per common stocks
  $0.13   $0.13   $0.29   $0.29 

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company had not experienced losses on this account.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the Company’s condensed balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 8).

 

Recently Issued Accounting Standards

 

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its financial statements.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

v3.23.2
Initial Public Offering
6 Months Ended
Jun. 30, 2023
Initial Public Offering [Abstract]  
INITIAL PUBLIC OFFERING

NOTE 3. INITIAL PUBLIC OFFERING

 

Pursuant to the Initial Public Offering, the Company sold 27,600,000 Units, which includes a full exercise by the underwriters of their over-allotment option in the amount of 3,600,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-fifth of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).

v3.23.2
Private Placement
6 Months Ended
Jun. 30, 2023
Private Placement [Abstract]  
PRIVATE PLACEMENT

NOTE 4. PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,270,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $7,270,000 in a private placement. Each Private Placement Warrant will be exercisable to purchase one share of Class A common stock at an exercise price of $11.50. The proceeds from the sale of Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless. As a result of the difference between the purchase price of the Private Placement Warrants of $1.00 and the fair value of $1.61, the Company recorded a change of $290,800 and $4,968,000 which is recorded in the change in fair value of warrant liability for the period ended June 30, 2023 and December 31, 2022, respectively.

v3.23.2
Related Party Transactions
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 5. RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On October 6, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 5,750,000 shares of the Company’s Class B common stock (the “Founder Shares”). Our Sponsor subsequently transferred certain shares to our officers and directors and other third parties in each case at the same per-share purchase price paid by our initial stockholders. On February 8, 2021, the Company effected a stock dividend of 0.2 shares of Class B common stock for each outstanding share of Class B common stock resulting in there being an aggregate of 6,900,000 Founder Shares outstanding. The Founder Shares will automatically convert into Class A common stock upon the consummation of a Business Combination on a one-for-one basis, subject to adjustments as described in Note 6. The Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture by the holders to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the initial stockholders will own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option, no Founder Shares are currently subject to forfeiture.

 

The holders of Founder Shares have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.

 

Related Party Advances

 

On December 30, 2021, the Company reimbursed MGG Investment Group LP, an affiliate of the Sponsor, $160,491 for payment of expenses in 2021 on behalf of the Company.

 

Related Party Loans

 

In order to finance transaction costs in connection with a Business Combination, the Company’s officer, directors, Sponsor or an affiliate of the foregoing, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination is not completed, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants.

 

Non-Redemption Agreements

 

In December 2022, the Company entered into Non-Redemption Agreements with various stockholders pursuant to which these stockholders have committed not to redeem their Public Shares. In consideration of these agreements, the Sponsor has agreed to transfer a portion of its Founder shares to the Non-Redeeming Stockholders at the closing of the Business Combination. The Company estimated the aggregate fair value of the 409,051 Founders Shares attributable to the Non-Redeeming Stockholders to be $163,620 or $0.40 per share. Each Non-Redeeming Stockholder acquired from the Sponsor an indirect economic interest in the Founder Shares. The excess of the fair value of the Founder Shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. The Company accounted for the transfer of a portion of the Sponsor’s Founders Shares to non-redeeming stockholders as a capital contribution by the Sponsor with a corresponding charge to additional paid-in capital to recognize the fair value of the shares transferred.

 

The fair value of the Founders Shares was based on the following significant inputs:

 

   December 30,
2022
 
Risk-free interest rate   4.49%
Remaining life of SPAC   1.75 
Underlying stock price  $10.12 
Probability of transaction   4.60%
v3.23.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 6. COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

Pursuant to a registration rights agreement entered into on February 8, 2021, the holders of the Founder Shares (and any shares of Class A common stock issued or issuable upon conversion of the Founder Shares), Private Placement Warrants (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants), and warrants (and any shares of Class A common stock issuable upon exercise of such warrants) that may be issued upon conversion of working capital loans have registration rights to require the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of the majority of these securities are entitled to make up to two demands that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriter’s Agreement

 

The underwriters from the Initial Public Offering are entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee will be forfeited by the underwriters solely in the event that the Company fails to complete a Business Combination, subject to the terms of the underwriting agreement.

v3.23.2
Stockholders' Deficit
6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' DEFICIT

NOTE 7. STOCKHOLDERS’ DEFICIT

 

Preferred Stock— The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.

 

Class A Common Stock— The Company is authorized to issue up to 125,000,000 shares of Class A, $0.0001 par value common stock. Holders of the Company’s shares of Class A common stock are entitled to one vote for each share.

 

At June 30, 2023 and December 31, 2022, there were 8,562,043 shares of Class A common stock issued and outstanding, 2,022,043 of which are presented as temporary equity. On December 30, 2022, public holders of an aggregate of 25,577,957 public shares exercised their right to redeem their public shares. The remaining 2,022,043 shares not redeemed are reflected in temporary equity, as these shares are subject to redemption upon the occurrence of events not solely within the Company’s control.

 

Class B Common Stock— The Company is authorized to issue up to 25,000,000 shares of Class B, $0.0001 par value common stock. Holders of the Company’s common stock are entitled to one vote for each share. On December 30, 2022, the Sponsor voluntarily converted 6,540,000 shares of Class B common stock of the Company it held as of such date into 6,540,000 shares of Class A common stock of the Company in accordance with the Charter. As a result, the Company has an aggregate of 360,000 shares of Class B common stock outstanding as of June 30, 2023 and December 31, 2022, respectively.

 

The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering, net of conversions, plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination, any private placement-equivalent securities issued, or to be issued, to any seller in a Business Combination, any private placement equivalent securities issued to the initial stockholders or their affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

 

On February 28, 2023, the Company received a written notice (the “Notice”) from the staff of NYSE Regulation (the “Staff”) of the New York Stock Exchange (“NYSE”) indicating that the Staff has determined to commence proceedings to delist the Company’s Class A Common Stock and units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable warrant (the “Units”), each warrant exercisable for one share of Class A Common Stock of the Company (the “Warrants”), from the NYSE pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000.

 

On July 21, 2023, the NYSE Office of General Counsel notified the Company that the Committee had determined to affirm the Staff’s decision to delist the Company’s Class A Common Stock and Units from the NYSE. Accordingly, the Class A Common Stock and units may be quoted and traded in the over-the-counter (“OTC”) market under the ticker symbols “PICC” and “PICCU,” respectively.

v3.23.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2023
Fair Value Measurements [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE 8. FAIR VALUE MEASUREMENTS

 

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

  Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
  Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
  Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

 

At June 30, 2023 and December 31, 2022, assets held in the Trust Account were $20,860,204 and $278,664,377, respectively, which is invested primarily in U.S. Treasury Securities. Through June 30, 2023 and December 31, 2022, the Company withdrew an amount of $0 and $1,112,748 from the interest earned on the Trust Account to pay franchise and income taxes, respectively.

 

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

   Level   December 31,
2022
   June 30,
2023
 
Assets:            
Marketable securities held in Trust Account  1   $278,664,377   $20,860,204 
Liabilities:              
Warrant Liability – Private Placement Warrants  2    363,500    72,700 
Warrant Liability – Public Warrants  1    276,000    55,200 

 

Warrant Liabilities

 

The Warrants were accounted for as liabilities in accordance with ASC815-40and are presented within warrant liabilities on our accompanying June 30, 2023 and December 31, 2022 balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed statements of operations.

 

The Public Warrants and the Private Warrants were initially valued using a Modified Black Scholes Option Pricing Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the common stock. The expected volatility as of the IPO date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing. A Monte Carlo simulation methodology was used in estimating the fair value of the public warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Warrants. For periods subsequent to the detachment of the warrants from the Units on February 11, 2021, the close price of the public warrant price will be used as the fair value as of each relevant date. At December 31, 2021 the Private Warrants transferred to Level 2 due to the use of an observable market quote for a similar asset in an active market.

 

At June 30, 2023, the values of the Public Warrants and Private Placement Warrants were $55,200 and $72,700, respectively, based on a fair value of $0.01 per warrant.

 

At December 31, 2022, the values of the Public Warrants and Private Placement Warrants were $276,000 and $363,500, respectively, based on a fair value of $0.05 per warrant.

 

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There are no transfers between the levels for the period ended June 30, 2023 or the year ended December 31, 2022.

 

The following table presents the changes in the fair value of warrant liabilities:

 

   Private
Placement
   Public   Warrant
Liabilities
 
Fair value as of December 31, 2022  $363,500   $276,000   $639,500 
Change in valuation inputs or other assumptions   
    
    
 
Fair value as of March 31, 2023  $363,500   $276,000   $639,500 
Change in valuation inputs or other assumptions   (290,800)   (220,800)   (511,600)
Fair value as of June 30, 2023  $72,700   $55,200   $127,900 
v3.23.2
Subsequent Events
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events, other than listed below, that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

On July 21, 2023, the NYSE Office of General Counsel notified the Company that the Committee had determined to affirm the Staff’s decision to delist the Company’s Class A Common Stock and Units from the NYSE. Accordingly, the Class A Common Stock and units may be quoted and traded in the over-the-counter (“OTC”) market under the ticker symbols “PICC” and “PICCU,” respectively.

 

August 11, 2023, a meeting was held to approve an additional extension. Based on the number of public shares that stockholders were seeking to redeem for cash and other factors that it deemed relevant, the Company’s management determined that the Extension was no longer in the best interests of the Company and its stockholders. Accordingly, on August 11, 2023, the Company reconvened the Meeting and then closed the Meeting without considering any business. As a result, the Company expects to redeem 100% of its outstanding public shares in accordance with the terms of its current amended and restated certificate of incorporation.

v3.23.2
Accounting Policies, by Policy (Policies)
6 Months Ended
Jun. 30, 2023
Significant Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2022, as filed with the SEC on March 30, 2023. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.

Emerging Growth Company

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

At June 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account are invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Offering Costs

Offering Costs

Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities were expensed as incurred in the condensed statements of operations. Offering costs associated with the Class A common stock issued were charged to temporary equity upon the completion of the Initial Public Offering. Offering costs amounting to $15,168,938 were charged to stockholders’ deficit upon the completion of the Initial Public Offering and $526,599 were expensed as of the date of the Initial Public Offering.

Class A Common Stock Subject to Possible Redemption

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement adjustment from carrying value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.

 

Components of Equity

Components of Equity

Upon the Initial Public Offering, the Company issued Class A common stock and Public Warrants. The Company also issued Private Placement Warrants. The Company allocated the proceeds received from the issuance using the with-and-without method. Under that method, the Company first allocated the proceeds to the Warrants based on their initial fair value measurement of $20,604,690 and then allocated the remaining proceeds, net of underwriting discounts and offering costs of $22,438,938 to the Class A common stock. On December 30, 2022, public holders of an aggregate of 25,577,957 public shares exercised their right to redeem their public shares. Following the shareholder redemption vote, the value of the 25,577,957 shares is reflected as a redemption payable. The remaining 2,022,043 of shares not redeemed are reflected in temporary equity, as these shares are subject to redemption upon the occurrence of events not solely within the Company’s control.

Warrant Liabilities

Warrant Liabilities

The Company assessed its warrants under ASC 480-25, “Distinguishing liabilities from equity” and ASC 815-40 “Derivatives and Hedging—Contracts in Entity’s Own Equity”. The Company accounts for the Public Warrants (as defined below) and Private Placement Warrants (collectively, the “Warrants”) as warrant liabilities. A provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Company accounts for Warrants for shares of the Company’s common stock that are not indexed to its own stock as derivative liabilities at fair value on the balance sheets and measured at fair value at inception (on the date of the Initial Public Offering) and at each reporting date in accordance with ASC 820, with changes in fair value recognized in the statements of operations in the period of change.

Income Taxes

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of June 30, 2023 and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it.

Our effective tax rates from continuing operations were 6.09% and 0.12% for the three months ended June 30, 2023 and 2022, respectively, and 11.51% and 0.06% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and six months ended June 30, 2023 and 2022, due to changes in fair value of warrant liabilities, and the valuation allowance on the deferred tax assets.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Net Income Per Common Share

Net Income Per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per common stock is computed by dividing net income by the weighted average number of common stocks outstanding for the period. The Company applies the two-class method in calculating earnings per share. Remeasurement adjustment associated with the redeemable shares of Class A common stocks is excluded from earnings per share as the redemption value approximates fair value.

The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 12,790,000 shares in the calculation of diluted net income per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

 

The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):

   For the Three Months Ended June 30, 2023   For the Six Months Ended June 30, 2023 
   Class A   Class A   Class B   Class A   Class A   Class B 
   Redeemable   Non-Redeemable   Redeemable   Redeemable   Non-Redeemable   Redeemable 
Basic and diluted net income per common stocks                        
Numerator:                        
Allocation of net income, as adjusted  $133,134   $430,602   $23,703   $126,128   $407,942   $22,456 
Denominator:                              
Basic and diluted weighted average common stocks outstanding
   2,022,043    6,540,000    360,000    2,022,043    6,540,000    360,000 
Basic and diluted net income per common stocks
  $0.07   $0.07   $0.07   $0.06   $0.06   $0.06 
   For the Three Months Ended
June 30, 2022
   For the Six Months Ended
June 30, 2022
 
   Class A   Class B   Class A   Class B 
Basic and diluted net income per common stocks                
Numerator:                
Allocation of net income, as adjusted  $3,692,064   $923,016   $8,050,666   $2,012,667 
Denominator:                    
Basic and diluted weighted average common stocks outstanding
   27,600,000    6,900,000    27,600,000    6,900,000 
Basic and diluted net income per common stocks
  $0.13   $0.13   $0.29   $0.29 
Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company had not experienced losses on this account.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the Company’s condensed balance sheets, primarily due to their short-term nature, except for warrant liabilities (see Note 8).

Recently Issued Accounting Standards

Recently Issued Accounting Standards

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its financial statements.

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

v3.23.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Schedule of Earnings Per Share Basic and Diluted The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):
   For the Three Months Ended June 30, 2023   For the Six Months Ended June 30, 2023 
   Class A   Class A   Class B   Class A   Class A   Class B 
   Redeemable   Non-Redeemable   Redeemable   Redeemable   Non-Redeemable   Redeemable 
Basic and diluted net income per common stocks                        
Numerator:                        
Allocation of net income, as adjusted  $133,134   $430,602   $23,703   $126,128   $407,942   $22,456 
Denominator:                              
Basic and diluted weighted average common stocks outstanding
   2,022,043    6,540,000    360,000    2,022,043    6,540,000    360,000 
Basic and diluted net income per common stocks
  $0.07   $0.07   $0.07   $0.06   $0.06   $0.06 
   For the Three Months Ended
June 30, 2022
   For the Six Months Ended
June 30, 2022
 
   Class A   Class B   Class A   Class B 
Basic and diluted net income per common stocks                
Numerator:                
Allocation of net income, as adjusted  $3,692,064   $923,016   $8,050,666   $2,012,667 
Denominator:                    
Basic and diluted weighted average common stocks outstanding
   27,600,000    6,900,000    27,600,000    6,900,000 
Basic and diluted net income per common stocks
  $0.13   $0.13   $0.29   $0.29 
v3.23.2
Related Party Transactions (Tables)
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
Schedule of Fair Value of the Founders Shares The fair value of the Founders Shares was based on the following significant inputs:
   December 30,
2022
 
Risk-free interest rate   4.49%
Remaining life of SPAC   1.75 
Underlying stock price  $10.12 
Probability of transaction   4.60%
v3.23.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Measurements [Abstract]  
Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
   Level   December 31,
2022
   June 30,
2023
 
Assets:            
Marketable securities held in Trust Account  1   $278,664,377   $20,860,204 
Liabilities:              
Warrant Liability – Private Placement Warrants  2    363,500    72,700 
Warrant Liability – Public Warrants  1    276,000    55,200 

 

Schedule of Changes in the Fair Value of Warrant Liabilities The following table presents the changes in the fair value of warrant liabilities:
   Private
Placement
   Public   Warrant
Liabilities
 
Fair value as of December 31, 2022  $363,500   $276,000   $639,500 
Change in valuation inputs or other assumptions   
    
    
 
Fair value as of March 31, 2023  $363,500   $276,000   $639,500 
Change in valuation inputs or other assumptions   (290,800)   (220,800)   (511,600)
Fair value as of June 30, 2023  $72,700   $55,200   $127,900 
v3.23.2
Description of Organization, Going Concern And Business Operations (Details) - USD ($)
6 Months Ended 12 Months Ended
Dec. 30, 2022
Aug. 16, 2022
Feb. 11, 2021
Jun. 30, 2023
Dec. 31, 2022
Description of Organization, Going Concern And Business Operations (Details) [Line Items]          
Exceeds per share (in Dollars per share)       $ 10  
Net proceeds     $ 276,000,000    
Transaction costs       $ 15,695,537  
Underwriting fees       5,520,000  
Deferred underwriting fees       9,660,000  
Other offering costs       $ 515,537  
Anticipated public per share (in Dollars per share)       $ 10  
Net tangible assets       $ 5,000,001  
Aggregate of public shares percentage       100.00%  
Aggregate public shares (in Shares) 2,022,043        
Cash         $ 258,248,749
Outstanding balance under redemption payable       $ 0 $ 258,248,749
Aggregate shares of common stock (in Shares)       163,620  
Per share (in Dollars per share)       $ 0.4  
Dissolution expenses       $ 100,000  
Excise tax rate   1.00%      
Operating bank accounts       29,096  
Securities held in the trust account       20,860,204  
Stockholders extension vote       1,953,720  
Deposit in the trust account       $ 640,000  
Initial Public Offering [Member]          
Description of Organization, Going Concern And Business Operations (Details) [Line Items]          
Net proceeds     $ 276,000,000    
Price per share (in Dollars per share)     $ 10    
Aggregate of public shares percentage       20.00%  
Private Placement Warrants [Member]          
Description of Organization, Going Concern And Business Operations (Details) [Line Items]          
Net proceeds       $ 7,270,000  
Sale of warrants (in Shares)       7,270,000  
Price per share (in Dollars per share)       $ 1  
Sponsor [Member]          
Description of Organization, Going Concern And Business Operations (Details) [Line Items]          
Exceeds per share (in Dollars per share)       10  
Warrant [Member]          
Description of Organization, Going Concern And Business Operations (Details) [Line Items]          
Price per share (in Dollars per share)       1  
Common Stock [Member]          
Description of Organization, Going Concern And Business Operations (Details) [Line Items]          
Shares of common stock (in Shares) 409,051        
Aggregate public shares (in Shares) 25,577,957        
Trust Account [Member]          
Description of Organization, Going Concern And Business Operations (Details) [Line Items]          
Exceeds per share (in Dollars per share)       10  
Class A Common Stock [Member] | Initial Public Offering [Member]          
Description of Organization, Going Concern And Business Operations (Details) [Line Items]          
Shares issued (in Shares)     27,600,000    
Exceeds per share (in Dollars per share)     $ 10    
Class A Common Stock [Member] | Over-Allotment Option [Member]          
Description of Organization, Going Concern And Business Operations (Details) [Line Items]          
Shares issued (in Shares)     3,600,000    
Exceeds per share (in Dollars per share)       $ 10  
U.S. federal [Member]          
Description of Organization, Going Concern And Business Operations (Details) [Line Items]          
Excise tax rate   1.00%      
v3.23.2
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 6 Months Ended
Dec. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Summary of Significant Accounting Policies (Details) [Line Items]          
Aggregate public shares (in Shares) 25,577,957        
Redemption payable shares (in Shares) 25,577,957        
Effective Income Tax Rate Reconciliation, Tax Credit, Percent   6.09% 0.12% 11.51% 0.06%
Statutory tax rate       21.00% 21.00%
FDIC insured amount (in Dollars)   $ 250,000   $ 250,000  
IPO [Member]          
Summary of Significant Accounting Policies (Details) [Line Items]          
Offering costs (in Dollars)   15,168,938   15,168,938  
Initial public offering (in Dollars)       526,599  
Initial fair value measurement of warrants (in Dollars)   $ 20,604,690   $ 20,604,690  
Warrant [Member]          
Summary of Significant Accounting Policies (Details) [Line Items]          
Aggregate purchase (in Shares)       12,790,000  
Class A Common Stock [Member]          
Summary of Significant Accounting Policies (Details) [Line Items]          
Temporary equity shares issued (in Shares) 2,022,043        
Class A Common Stock [Member] | IPO [Member]          
Summary of Significant Accounting Policies (Details) [Line Items]          
Underwriting expense (in Dollars)       $ 22,438,938  
v3.23.2
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Class A Redeemable [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted [Line Items]        
Allocation of net income, as adjusted $ 133,134   $ 126,128  
Basic and diluted weighted average common stocks outstanding 2,022,043   2,022,043  
Basic and diluted net income per common stocks $ 0.07   $ 0.06  
Class A Non-Redeemable [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted [Line Items]        
Allocation of net income, as adjusted $ 430,602   $ 407,942  
Basic and diluted weighted average common stocks outstanding 6,540,000   6,540,000  
Basic and diluted net income per common stocks $ 0.07   $ 0.06  
Class B Redeemable [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted [Line Items]        
Allocation of net income, as adjusted $ 23,703   $ 22,456  
Basic and diluted weighted average common stocks outstanding 360,000   360,000  
Basic and diluted net income per common stocks $ 0.07   $ 0.06  
Class A [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted [Line Items]        
Allocation of net income, as adjusted   $ 3,692,064   $ 8,050,666
Basic and diluted weighted average common stocks outstanding   27,600,000   27,600,000
Basic and diluted net income per common stocks   $ 0.13   $ 0.29
Class B [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted [Line Items]        
Allocation of net income, as adjusted   $ 923,016   $ 2,012,667
Basic and diluted weighted average common stocks outstanding   6,900,000   6,900,000
Basic and diluted net income per common stocks $ 0.07 $ 0.13 $ 0.06 $ 0.29
v3.23.2
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted (Parentheticals) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Class A Redeemable [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted (Parentheticals) [Line Items]        
Diluted weighted average common stocks outstanding 2,022,043   2,022,043  
Diluted net income per common stocks $ 0.07   $ 0.06  
Class A Non-Redeemable [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted (Parentheticals) [Line Items]        
Diluted weighted average common stocks outstanding 6,540,000   6,540,000  
Diluted net income per common stocks $ 0.07   $ 0.06  
Class B Redeemable [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted (Parentheticals) [Line Items]        
Diluted weighted average common stocks outstanding 360,000   360,000  
Diluted net income per common stocks $ 0.07   $ 0.06  
Class A [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted (Parentheticals) [Line Items]        
Diluted weighted average common stocks outstanding   27,600,000   27,600,000
Diluted net income per common stocks   $ 0.13   $ 0.29
Class B [Member]        
Summary of Significant Accounting Policies (Details) - Schedule of Earnings Per Share Basic and Diluted (Parentheticals) [Line Items]        
Diluted weighted average common stocks outstanding   6,900,000   6,900,000
Diluted net income per common stocks $ 0.07 $ 0.13 $ 0.06 $ 0.29
v3.23.2
Initial Public Offering (Details) - Class A Common Stock [Member] - $ / shares
6 Months Ended
Jun. 30, 2023
Feb. 11, 2021
IPO [Member]    
Initial Public Offering (Details) [Line Items]    
Sold shares 27,600,000  
Purchase price   $ 10
Over-Allotment Option [Member]    
Initial Public Offering (Details) [Line Items]    
Sold shares 3,600,000  
Purchase price $ 10  
Public Warrants [Member]    
Initial Public Offering (Details) [Line Items]    
Warrant price $ 11.5  
v3.23.2
Private Placement (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Private Placement (Details) [Line Items]          
Aggregate purchase price (in Dollars)     $ 7,270,000    
Exercise price $ 0.01   $ 0.01   $ 0.05
Fair value of warrants liability (in Dollars) $ (511,600) $ (4,476,500) $ (511,600) $ (10,743,600)  
Private Placement [Member]          
Private Placement (Details) [Line Items]          
Aggregate shares (in Shares)     7,270,000    
Price per share $ 1   $ 1    
Exercise price 1.61   $ 1.61   $ 4,968,000
Fair value of warrants liability (in Dollars)     $ 290,800    
Class A Common Stock [Member] | Public Warrants [Member]          
Private Placement (Details) [Line Items]          
Exercise price 11.5   $ 11.5    
Sponsor [Member] | Private Placement [Member]          
Private Placement (Details) [Line Items]          
Price per share $ 1   $ 1    
v3.23.2
Related Party Transactions (Details) - USD ($)
6 Months Ended 12 Months Ended
Feb. 08, 2021
Oct. 06, 2020
Jun. 30, 2023
Dec. 31, 2022
Dec. 30, 2021
Related Party Transactions (Details) [Line Items]          
Payment of expenses         $ 160,491
Class B Common Stock [Member]          
Related Party Transactions (Details) [Line Items]          
Subject to forfeiture, shares 900,000        
Class A Common Stock [Member]          
Related Party Transactions (Details) [Line Items]          
Common stock shares outstanding     8,562,043 8,562,043  
Working Capital Loan [Member]          
Related Party Transactions (Details) [Line Items]          
Working capital loans     $ 1,500,000    
Price per warrant     $ 1    
Non-Redemption Agreements [Member]          
Related Party Transactions (Details) [Line Items]          
Founder shares       409,051  
Stockholders       $ 163,620  
Per share       $ 0.4  
Sponsor [Member]          
Related Party Transactions (Details) [Line Items]          
Offering and formation costs   $ 25,000      
Exchange for issuance, shares   5,750,000      
Sponsor [Member] | Class B Common Stock [Member]          
Related Party Transactions (Details) [Line Items]          
Stock dividend 0.2        
Common stock shares outstanding 6,900,000        
Common stock issued and outstanding percentage 20.00%        
Sponsor [Member] | Class A Common Stock [Member]          
Related Party Transactions (Details) [Line Items]          
Exceeds per share     $ 12    
v3.23.2
Related Party Transactions (Details) - Schedule of Fair Value of the Founders Shares
12 Months Ended
Dec. 30, 2022
USD ($)
Schedule of fair value of the founders shares [Abstract]  
Risk-free interest rate 4.49%
Remaining life of SPAC 1 year 9 months
Underlying stock price (in Dollars) $ 10.12
Probability of transaction 4.60%
v3.23.2
Commitments and Contingencies (Details)
Jun. 30, 2023
USD ($)
$ / shares
Commitments and Contingencies Disclosure [Abstract]  
Deferred fee per unit | $ / shares $ 0.35
Deferred fee amount | $ $ 9,660,000
v3.23.2
Stockholders' Deficit (Details)
6 Months Ended 12 Months Ended
Feb. 28, 2023
USD ($)
Dec. 30, 2022
shares
Jun. 30, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Stockholders' Deficit (Details) [Line Items]        
Preferred stock shares authorized     1,000,000 1,000,000
Preferred stock par or stated value per share (in Dollars per share) | $ / shares     $ 0.0001 $ 0.0001
Preferred stock shares issued    
Preferred stock shares outstanding    
Description of voting rights     Holders of the Company’s common stock are entitled to one vote for each share  
Converted basis percentage     20.00%  
Trading day 30      
Least amount (in Dollars) | $ $ 40,000,000      
Class A Common Stock [Member]        
Stockholders' Deficit (Details) [Line Items]        
Common stock shares authorized     125,000,000 125,000,000
Common stock par or stated value per share (in Dollars per share) | $ / shares     $ 0.0001 $ 0.0001
Common stock, shares issued     8,562,043 8,562,043
Common stock, shares outstanding     8,562,043 8,562,043
Common stock subject to possible redemption, shares outstanding   2,022,043 2,022,043 2,022,043
Aggregate public shares   25,577,957    
Class A Common Stock [Member] | Sponsor [Member]        
Stockholders' Deficit (Details) [Line Items]        
Common stock subject to possible redemption, shares outstanding     2,022,043  
Sponsor voluntarily converted shares   6,540,000    
Class B Common Stock [Member]        
Stockholders' Deficit (Details) [Line Items]        
Common stock shares authorized     25,000,000 25,000,000
Common stock par or stated value per share (in Dollars per share) | $ / shares     $ 0.0001 $ 0.0001
Aggregate of shares     360,000 360,000
Class B Common Stock [Member] | Sponsor [Member]        
Stockholders' Deficit (Details) [Line Items]        
Sponsor voluntarily converted shares   6,540,000    
v3.23.2
Fair Value Measurements (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Fair Value Measurements (Details) [Line Items]    
Assets held in the trust account $ 20,860,204 $ 278,664,377
Trust account to pay franchise and income taxes $ 0 $ 1,112,748
Private placement warrants, description The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed statements of operations.  
Warrant price (in Dollars per share) $ 0.01 $ 0.05
Public Warrants [Member]    
Fair Value Measurements (Details) [Line Items]    
Fair value of warrants $ 55,200 $ 276,000
Private Placement Warrants [Member]    
Fair Value Measurements (Details) [Line Items]    
Fair value of warrants $ 72,700 $ 363,500
Warrant price (in Dollars per share) $ 1.61 $ 4,968,000
v3.23.2
Fair Value Measurements (Details) - Schedule of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Level 1 [Member]    
Assets:    
Marketable securities held in Trust Account $ 20,860,204 $ 278,664,377
Level 1 [Member] | Public Warrants [Member]    
Liabilities:    
Warrant Liability 55,200 276,000
Level 2 [Member] | Private Placement Warrants [Member]    
Liabilities:    
Warrant Liability $ 72,700 $ 363,500
v3.23.2
Fair Value Measurements (Details) - Schedule of Changes in the Fair Value of Warrant Liabilities - USD ($)
3 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Private Placement [Member]    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Fair value as of beginning $ 363,500 $ 363,500
Change in valuation inputs or other assumptions (290,800)
Fair value as of ending 72,700 363,500
Public [Member]    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Fair value as of beginning 276,000 276,000
Change in valuation inputs or other assumptions (220,800)
Fair value as of ending 55,200 276,000
Warrant Liabilities [Member]    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Fair value as of beginning 639,500 639,500
Change in valuation inputs or other assumptions (511,600)
Fair value as of ending $ 127,900 $ 639,500
v3.23.2
Subsequent Events (Details)
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
Redeem outstanding percentage 100.00%

Pivotal Investment Corpo... (NYSE:PICC)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Pivotal Investment Corpo....
Pivotal Investment Corpo... (NYSE:PICC)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Pivotal Investment Corpo....